[1]
“USE OF ENDOBRONCHIAL VALVE IN PATIENTS WITH THE EMPHYSEMATOUS PHENOTYPE OF COPD”, RECIMA21, vol. 5, no. 10, p. e5105671, Oct. 2024, doi: 10.47820/recima21.v5i10.5671.